Cite
HARVARD Citation
Kutlu, Y. et al. (2023). Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with extensive-stage small cell lung cancer treated with atezolizumab in combination with chemotherapy. Medicine. 102 (15), pp. e33432-. [Online].